CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2022-10-02 鸡爪

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？

55 0

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2022-09-19 ms5000001982894673

偏重的研究方向：肿瘤
经验分享：各位大神，CR送外审不会发邮件通知么？

61 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2022-05-24 杨明月字九州

各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？

61 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2021-01-12 1215c911m91暂无昵称

投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。

190 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2022-01-08 Tou gao小菜鸡

请问各位大佬，共一第一申请国青有望吗?

92 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2022-04-26 ms1000001245672662

投稿命中率:95.0
经验分享：2255

89 0

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2020-03-11 doctor杨

二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表::
老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表:
老哥，二审一般多久under review啊

zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊

95 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2019-02-02 1252364am52(暂无昵称)

第一稿，大修

Stage Start Date
Revision Received 2018-10-30
Revision Abandoned 2018-10-01
Waiting for Revision 2018-05-29
Decision Sent to Author 2018-05-29
Under Review 2018-05-26
Decision Pending 2018-05-26
Under Review 2018-04-23
Under Editorial Consideration 2018-04-23
Initial QC 2018-04-22
Manuscript Submission 2018-04-22
第二稿，小修

Stage Start Date
Revision Received 2018-12-08
Waiting for Revision 2018-12-06
Decision Sent to Author 2018-12-06
Under Review 2018-12-05
Decision Pending 2018-12-05
Under Review 2018-11-14
Under Editorial Consideration 2018-10-30
Manuscript Submission 2018-10-30
第三稿，格式修改
Stage Start Date
Revision Received 2019-01-14
Waiting for Revision 2019-01-14
Decision Sent to Author 2019-01-14
Under Review 2019-01-10
Decision Pending 2019-01-10
Under Review 2018-12-21
Under Editorial Consideration 2018-12-10
Manuscript Submission 2018-12-08
第四稿，接收
Stage Start Date
Manuscript Ready for Publication 2019-02-01
Decision Sent to Author 2019-02-01
Under Review 2019-02-01
Decision Pending 2019-02-01
Under Review 2019-02-01
Under Editorial Consideration 2019-01-14
Manuscript Submission 2019-01-14
开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。

449 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2019-07-05 tomsyu

我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表::
你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表:
你的还没消息吗？要修几次啊

科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊

128 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2091472, encodeId=58fc20914e26f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问如果送外审了，大概多久会收到消息啊？一般拒稿多还是大修多？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96225514779, createdName=鸡爪, createdTime=Sun Oct 02 14:16:17 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089093, encodeId=3b14208909313, content=偏重的研究方向：肿瘤 经验分享：各位大神，CR送外审不会发邮件通知么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe6455220, createdName=ms5000001982894673, createdTime=Mon Sep 19 20:06:42 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221940, encodeId=3be41221940ea, content=各位大佬，我的状态under review不到一天，就变成了decision pending，是什么情况呢？被拒的概率有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/fd17e834e6ec487588bf31e346c44a8d/90906d8da92c4d24b107d214053b514b.jpg, createdBy=992a5376396, createdName=杨明月字九州, createdTime=Tue May 24 09:54:28 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916036, encodeId=fdee91603672, content=投了一篇，几天就拒稿了。内容数据创新都比里边文章不差，感觉越来越难，越来越严格。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Tue Jan 12 20:47:04 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182365, encodeId=d89a1182365b3, content=请问各位大佬，共一第一申请国青有望吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8fb42104454, createdName=Tou gao小菜鸡, createdTime=Sat Jan 08 22:05:49 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214370, encodeId=4ecd12143e049, content=投稿命中率:95.0 经验分享：2255, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=978b6414011, createdName=ms1000001245672662, createdTime=Tue Apr 26 00:56:18 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586349, encodeId=014c586349ea, content=二审提交后staff会先审格式，格式合格之后就直接under review了zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊zyg1 2020-03-10 00:00:00 发表: 老哥，二审一般多久under review啊, beContent=zyg1 2020-03-10 发表:: 老哥，二审一般多久under review啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Wed Mar 11 00:00:00 CST 2020, time=2020-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566430, encodeId=c99e566430ea, content=第一稿，大修 Stage Start Date Revision Received 2018-10-30 Revision Abandoned 2018-10-01 Waiting for Revision 2018-05-29 Decision Sent to Author 2018-05-29 Under Review 2018-05-26 Decision Pending 2018-05-26 Under Review 2018-04-23 Under Editorial Consideration 2018-04-23 Initial QC 2018-04-22 Manuscript Submission 2018-04-22 第二稿，小修 Stage Start Date Revision Received 2018-12-08 Waiting for Revision 2018-12-06 Decision Sent to Author 2018-12-06 Under Review 2018-12-05 Decision Pending 2018-12-05 Under Review 2018-11-14 Under Editorial Consideration 2018-10-30 Manuscript Submission 2018-10-30 第三稿，格式修改 Stage Start Date Revision Received 2019-01-14 Waiting for Revision 2019-01-14 Decision Sent to Author 2019-01-14 Under Review 2019-01-10 Decision Pending 2019-01-10 Under Review 2018-12-21 Under Editorial Consideration 2018-12-10 Manuscript Submission 2018-12-08 第四稿，接收 Stage Start Date Manuscript Ready for Publication 2019-02-01 Decision Sent to Author 2019-02-01 Under Review 2019-02-01 Decision Pending 2019-02-01 Under Review 2019-02-01 Under Editorial Consideration 2019-01-14 Manuscript Submission 2019-01-14 开始对格式要求较低，此后越来越高，费时费力，从业十年来，最辛苦的文章，比更高档次的杂志都繁琐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=449, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ca2542103, createdName=1252364am52(暂无昵称), createdTime=Sat Feb 02 13:49:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573362, encodeId=4a055e336274, content=我修的第二次已经提交回去了，正等着结果呢科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊科研小将 2019-07-01 00:00:00 发表: 你的还没消息吗？要修几次啊, beContent=科研小将 2019-07-01 发表:: 你的还没消息吗？要修几次啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574487, encodeId=25525e44877e, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：第一稿大修 Revision Received 2019-07-06 09:47:41 Waiting for Revision 2019-04-10 09:43:33 Decision Sent to Author 2019-04-10 09:43:33 Under Review 2019-04-08 16:05:10 Decision Pending 2019-04-08 16:04:44 Under Review 2019-03-21 20:30:37 Under Editorial Consideration 2019-03-21 14:23:44 Initial QC 2019-03-21 00:25:43 第二稿暂时接受编辑改了题目，润色摘要 Revision Received 2019-08-03 20:32:18 Waiting for Revision 2019-08-02 14:06:05 Decision Sent to Author 2019-08-02 14:06:05 Under Review 2019-07-31 09:08:37 Decision Pending 2019-07-31 09:08:29 Under Review 2019-07-11 10:26:42 Under Editorial Consideration 2019-07-09 06:59:37 Manuscript Submission 2019-07-06 09:47:41, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=efd65156030, createdName=43753108, createdTime=Tue Aug 06 15:45:00 CST 2019, time=2019-08-06, status=1, ipAttribution=)]

2019-08-06 43753108

审稿速度:1.0 | 投稿命中率:25.0
经验分享：第一稿大修
Revision Received 2019-07-06 09:47:41
Waiting for Revision 2019-04-10 09:43:33
Decision Sent to Author 2019-04-10 09:43:33
Under Review 2019-04-08 16:05:10
Decision Pending 2019-04-08 16:04:44
Under Review 2019-03-21 20:30:37
Under Editorial Consideration 2019-03-21 14:23:44
Initial QC 2019-03-21 00:25:43
第二稿暂时接受编辑改了题目，润色摘要
Revision Received 2019-08-03 20:32:18
Waiting for Revision 2019-08-02 14:06:05
Decision Sent to Author 2019-08-02 14:06:05
Under Review 2019-07-31 09:08:37
Decision Pending 2019-07-31 09:08:29
Under Review 2019-07-11 10:26:42
Under Editorial Consideration 2019-07-09 06:59:37
Manuscript Submission 2019-07-06 09:47:41

96 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务